Imel, E. A., Chen, A., Chang, T., Roberts, M. S., & Ward, L. M. (2020). SUN-356 Burosumab Resulted in Greater Clinical Improvements Compared with Higher-dose Conventional Therapy in Children with X-linked Hypophosphatemia (XLH). J Endocr Soc.
Styl ChicagoImel, Erik A., Angel Chen, Ting Chang, Mary Scott Roberts, a Leanne Marie Ward. "SUN-356 Burosumab Resulted in Greater Clinical Improvements Compared With Higher-dose Conventional Therapy in Children With X-linked Hypophosphatemia (XLH)." J Endocr Soc 2020.
Citace podle MLAImel, Erik A., et al. "SUN-356 Burosumab Resulted in Greater Clinical Improvements Compared With Higher-dose Conventional Therapy in Children With X-linked Hypophosphatemia (XLH)." J Endocr Soc 2020.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..